Taiwan researchers identify Klebsiella strain with novel resistance mechanism

A joint investigation by National Yang Ming Chiao Tung University and Taipei Veterans’ General Hospital revealed a Klebsiella pneumoniae strain harboring a tetrapeptide sequence—tyrosine-arginine-isoleucine-threonine (YRIT)—that blocks the penicillin-binding protein 3 site, rendering the bacteria resistant to penicillins, cephalosporins and monobactams. The mutation was identified in urine and phlegm samples from two patients who had no contact with each other during the COVID-19 pandemic.

This marks the first documented case in Taiwan of a non-E. coli organism producing the YRIT sequence, and the strain also carries additional mutations that boost its contagiousness. Scientists warn that any further mutation could make the pathogen impervious to existing drug classes, posing a serious public-health risk. The findings highlight an urgent need for systematic monitoring of bacterial genetics, development of new antibiotics, and stricter patient containment protocols.